Xeltis' Technology for Natural Heart Valve Restoration Featured as the Future of Valve Therapy at EuroPCR

Dedicated plenary session on Endogenous Tissue Restoration (ETR) previews first data from aortic valve preclinical studies PARIS, May 17, 2017 -- (Healthcare Sales & Marketing Network) -- A pioneering approach to heart valve therapy from Swiss-Dutch cl... Devices, Interventional, Cardiology Xeltis , Endogenous Tissue Restoration, heart valve therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news